1. Hatzitolios A, Savopoulos C, Ntaios G, Papadidaskalou F, Dimitrakoudi E, Kosmidou M, et al. Stroke and conditions that mimic it: a protocol secures a safe early recognition. Hippokratia. 2008; 12:98–102.
2. Magauran BG Jr, Nitka M. Stroke mimics. Emerg Med Clin North Am. 2012; 30:795–804.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Libman RB, Wirkowski E, Alvir J, Rao TH. Conditions that mimic stroke in the emergency department: implications for acute stroke trials. Arch Neurol. 1995; 52:1119–1122.
4. Förster A, Griebe M, Wolf ME, Szabo K, Hennerici MG, Kern R. How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol. 2012; 259:1347–1353.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Norris JW, Hachinski VC. Misdiagnosis of stroke. Lancet. 1982; 1:328–331.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Zinkstok SM, Engelter ST, Gensicke H, Lyrer PA, Ringleb PA, Artto V, et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke. 2013; 44:1080–1084.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Winkler DT, Fluri F, Fuhr P, Wetzel SG, Lyrer PA, Ruegg S, et al. Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke. 2009; 40:1522–1525.
8. Guillan M, Alonso-Canovas A, Gonzalez-Valcarcel J, Garcia Barragan N, Garcia Caldentey J, Hernandez-Medrano I, et al. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovasc Dis. 2012; 34:115–120.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke. 2006; 37:769–775.
10. Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, et al. A model to prevent fibrinolysis in patients with stroke mimics. J Stroke Cerebrovasc Dis. 2012; 21:839–843.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998; 352:1245–1251.
12. Tsivgoulis G, Alexandrov AV, Chang J, Sharma VK, Hoover SL, Lao AY, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke. 2011; 42:1771–1774.
13. Chernyshev OY, Martin-Schild S, Albright KC, Barreto A, Misra V, Acosta I, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology. 2010; 74:1340–1345.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Groch SN, Hurwitz LJ, Wright IS, McDowell F. Intracranial lesions simulating cerebral thrombosis. JAMA. 1960; 172:1469–1472.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Brunser AM, Illanes S, Lavados PM, Muñoz P, Cárcamo D, Hoppe A, et al. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J Stroke Cerebrovasc Dis. 2013; 22:1140–1145.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Silverman IE, Restrepo L, Mathews GC. The relevance of post-stroke seizures. Arch Neurol. 2002; 59:195–201.
17. Brainin M, Heiss WD. Textbook of stroke medicine. Cambridge: Cambridge University Press;2010.